Achaogen, an emerging biopharmaceutical company addressing the issue of multi-drug resistant bacterial infections through the discovery and development of innovative broad-spectrum antibiotics, today announced that it has received a £4.1 million Seeding Drug Discovery award from the Wellcome Trust. Complete news at...
In the January 8, 2008 issue of The New England Journal of Medicine (NEJM), schistosomiasis expert Charles H. King M.D., Professor of International Health at the Center for Global Health and Diseases at Case Western Reserve University School of Medicine concludes global eradication of schistosomiasis is feasible if the current infection control strategy shifts to a proactive, comprehensive elimination strategy. Dr. King supports the community-based trial by Wang et al. Complete news at...
A preclinical study found a new nasal spray vaccine to provide complete protection against a major botulism toxin, according to a study published in the Nature journal Gene Therapy. Botulism is caused by a bacterium, Clostridium botulinum, which produces toxins that cause paralysis and often death, as the muscles that control breathing fail. Out of an average of 145 U.S. Complete news at...
Animal species that sleep for longer do not suffer as much from parasite infestation and have a greater concentration of immune cells in their blood according to a study published in the open-access journal BMC Evolutionary Biology. The question of why we sleep has long puzzled scientists. Complete news at...
Scientists at St. Jude Children's Research Hospital have demonstrated a more effective treatment for bacterial pneumonia following influenza. They found that the antibiotics clindamycin and azithromycin, which kill bacteria by inhibiting their protein synthesis, are more effective than a standard first-line treatment with the "beta-lactam" antibiotic ampicillin, which causes the bacteria to lyse, or burst. Complete news at...
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment